Company profile for Corner Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Corner is leading the way in developing a novel class of immunotherapies. Our groundbreaking dendritic cell hyperactivation (hDC) platform stands out for its versatility in targeting a wide array of cancers and infectious diseases. By leveraging this platform, we can stimulate potent memory T cell responses, leading to strong and lasting immunity. Our goal at Corner is to revolutionize the standard of care by introducing robus...
Corner is leading the way in developing a novel class of immunotherapies. Our groundbreaking dendritic cell hyperactivation (hDC) platform stands out for its versatility in targeting a wide array of cancers and infectious diseases. By leveraging this platform, we can stimulate potent memory T cell responses, leading to strong and lasting immunity. Our goal at Corner is to revolutionize the standard of care by introducing robust, rapid, patient-friendly, and cost-effective immunotherapies, even for the most challenging diseases to treat.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Watertown MA 02472
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-09-18/corner-therapeutics-appoints-biotech-pioneer-john-maraganore-as-strategic-adviser

PHARMAWEB
18 Sep 2025

https://www.businesswire.com/news/home/20250908300499/en/Corner-Therapeutics-Research-Opens-Path-to-Universal-Long-Lasting-Flu-Vaccine-and-Signals-Promise-for-Oncology

BUSINESSWIRE
08 Sep 2025

https://www.businesswire.com/news/home/20250624230485/en/Corner-Therapeutics-to-Present-New-Preclinical-and-Human-Data-on-mRNA-Encoded-Immunotherapies-at-FOCiS-2025

BUSINESSWIRE
24 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty